Kaia Health Named to NYC Digital Health 100 by NYCHBL

New York, NY (February 1, 2022) – Kaia Health, the digital therapeutics company on a mission to democratize access to healthcare, today announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to New York’s healthcare ecosystem, has recognized the company on its NYC Digital Health 100, showcasing the most exciting and innovative health start-ups in New York.

“We’re proud to be a part of New York City’s dynamic healthcare scene,” said Nigel Ohrenstein, President, Kaia Health. “Being named to the NYC Digital Health 100 is a testament to the commitment and mission our team keeps top of mind day-in and day-out working for a future with truly accessible, affordable, quality healthcare for all.”

“This year, the NYC Digital Health 100 is comprised of an incredibly diverse set of companies and leaders who are working to innovate and solve some of the most complex challenges across all facets of the healthcare ecosystem,” said Bunny Ellerin, co-founder and CEO, NYCHBL. “We are delighted to recognize these companies and celebrate and support their growth in the New York area.”

After a banner year in 2021, Kaia Health has started 2022 incredibly well with the addition of more than 50 new clients from a wide range of industries, including 10 Fortune 500 employers. Powerful clinical trial results and a strong capital round have helped build the foundation for this growth. Results of the largest randomized controlled trial in the digital MSK industry showed Kaia Health cut costs by 80% compared to more traditional treatments. These results followed a highly successful $75 million Series C funding round, which is helping to further the company’s mission to solve the biggest healthcare challenges of accessible, equitable, affordable, and high-quality care.

The NYC Digital Health 100 was released in conjunction with the NYCHBL Healthcare Innovation Report 2022, an in-depth look at the data, trends, and insights that define the healthcare industry in NY. In 2021, 182 companies raised an historic high of $9.0B, a 150% increase from 2020 ($3.6B) and 87% of the investments went to start-ups in areas including virtual care, patient engagement, and mental health. To review the report, please visit https://bit.ly/dh100-pr.

NYC Digital Health 100 Methodology

To compile the NYC Digital Health 100, NYCHBL used its dynamic database of digital health companies in the region and then invited companies to complete applications with quantitative and qualitative data to broaden the consideration set. A company qualified for consideration if it maintained headquarters or an office (over 10 people) in the New York region. Companies were judged on a number of factors, including but not limited to: strength of leadership, # of employees, funding (if known), revenue (if known), market fit, differentiated offerings, approach to diversity and equity, and community engagement.

Media inquiries:

Kaia Health President Nigel Ohrenstein is available for interviews.

Media contact:

Jessy Green

jessy.green@svmpr.com

(917) 689-9295

About Kaia Health
Kaia Health is a digital therapeutics company that creates accessible, evidence-based treatments for a range of conditions, including MSK pain and COPD. Kaia Health covers 60 million lives globally, and its clinically proven motion analysis capability is transforming and democratizing healthcare through technology that patients can access anytime, anywhere, with the camera of their smartphone or tablet. Kaia Health is the most clinically validated digital MSK provider, and its motion analysis technology is as accurate as physical therapists in suggesting exercise corrections, resulting in equitable care regardless of BMI, age, gender, or location. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and has offices in New York and Munich. Learn more at www.kaiahealth.com.